Healthcare

Investors are marking their calendars for a pivotal date in late February 2026. National Healthcare is poised to release its...

Biopharmaceutical firm aTyr Pharma (ATYR) has scheduled a critical regulatory discussion with the U.S. Food and Drug Administration (FDA) for...

All eyes are on Align Technology as the company prepares to release its fourth-quarter financial results after today's market close....

Biotechnology firm Bionxt Solutions has moved a step closer to testing a novel multiple sclerosis treatment in humans. The company's...

ImmunityBio has initiated a new clinical study, marking a strategic expansion of its development pipeline. The U.S. biotechnology firm announced...

Acadia Pharmaceuticals has encountered a significant obstacle for its European expansion strategy. Market uncertainty followed the announcement of a negative...

Shares of UnitedHealth Group came under significant pressure this week following a regulatory announcement that fell dramatically short of industry...

ImmunityBio has entered February with significant operational momentum, driven by surging revenue, greater clarity from U.S. regulators, and initial international...

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic...

Investor attention is turning to Bio-Rad Laboratories as the company prepares to release its fourth-quarter and full-year 2025 financial results....